Study to Investigate the Clinical Outcomes of Different Regimens of Myfortic in De Novo Kidney Tx Pts Using Simulect and Neoral With or Without Steroids.

Trial Profile

Study to Investigate the Clinical Outcomes of Different Regimens of Myfortic in De Novo Kidney Tx Pts Using Simulect and Neoral With or Without Steroids.

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Jan 2011

At a glance

  • Drugs Mycophenolate sodium (Primary) ; Basiliximab; Ciclosporin; Methylprednisolone; Prednisolone
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Acronyms FREEDOM
  • Sponsors Novartis; Novartis Pharmaceuticals
  • Most Recent Events

    • 28 Jan 2011 Actual end date (May 2005) added as reported by ClinicalTrials.gov.
    • 18 Sep 2006 Status change
    • 28 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top